Cryo-Cell International, Inc.
CCEL
$3.10
$0.165.44%
AMEX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.84M | 7.83M | 7.93M | 7.97M | 8.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.84M | 7.83M | 7.93M | 7.97M | 8.02M |
| Cost of Revenue | 6.09M | 1.80M | 1.86M | 1.98M | 1.64M |
| Gross Profit | 1.75M | 6.02M | 6.07M | 5.98M | 6.39M |
| SG&A Expenses | 5.45M | 3.88M | 4.26M | 4.64M | 6.01M |
| Depreciation & Amortization | 183.80K | 185.70K | 190.10K | 191.90K | 196.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.81M | 5.92M | 6.44M | 6.91M | 8.15M |
| Operating Income | -3.97M | 1.90M | 1.49M | 1.06M | -122.30K |
| Income Before Tax | -4.63M | 1.19M | 575.10K | 533.70K | -842.40K |
| Income Tax Expenses | -814.50K | 436.60K | 219.30K | 250.90K | 1.02M |
| Earnings from Continuing Operations | -3.82M | 749.40K | 355.80K | 282.90K | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.82M | 749.40K | 355.80K | 282.90K | -1.86M |
| EBIT | -3.97M | 1.90M | 1.49M | 1.06M | -122.30K |
| EBITDA | -3.72M | 2.14M | 1.74M | 1.30M | 126.70K |
| EPS Basic | -0.47 | 0.09 | 0.04 | 0.04 | -0.23 |
| Normalized Basic EPS | -0.34 | 0.11 | 0.07 | 0.04 | -0.07 |
| EPS Diluted | -0.47 | 0.09 | 0.04 | 0.03 | -0.23 |
| Normalized Diluted EPS | -0.34 | 0.11 | 0.07 | 0.04 | -0.07 |
| Average Basic Shares Outstanding | 8.06M | 8.06M | 8.08M | 8.08M | 8.07M |
| Average Diluted Shares Outstanding | 8.06M | 8.07M | 8.13M | 8.20M | 8.07M |
| Dividend Per Share | 0.00 | 0.00 | 0.15 | 0.25 | 0.25 |
| Payout Ratio | 0.00% | 0.00% | 340.29% | 714.34% | -108.54% |